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ABSTRACT
Breast cancer is the leading cause of cancer related mortality in women. The estimated
new cases and death for 2010 in the US for females were 207,090 and 39,840 and for men were
1,970 and 390 respectively. Breast cancer cells contain cancer stem cells (CSCs), which
represent less than 5% of the total cancer cell population, but accounts for continuous
proliferation and growth. Breast cancer is highly metastatic and can spread to various parts of the
body. Signaling through cell surface markers, including CD44/CD24/ALDH1 in breast cancer,
pro-survival factors, including Hsp90 and other client proteins, angiogenic biomarkers and
telomerase activity are essential for cancer cell renewal and could represent putative targets for
inhibiting breast cancer cell development. The aim of this research was to determine the in vitro
anti-carcinogenic property of ginger oil against breast cancer cells (MDA-MB-231). We
investigated the inhibitory activity of ginger oil against the biomarkers that are essential for
breast cancer cell viability or proliferation. Cells were incubated with vehicle (DMSO), or ginger
oil at concentrations, 0.05% to 0.2% of the volume of the media for 72 h at 37 °C and 5% CO2.
Ginger oil dose-dependently inhibited the viability and proliferation of breast cancer cells in
vitro. The mechanism of breast cancer cell inhibition included induction of caspase-mediated
apoptosis, cell cycle arrest, inhibition of Hsp90 and some of its client proteins, down-regulation
of cell surface biomarkers, CD44/ALDH1 in breast cancer cells, inhibition of the biomarkers of
angiogenesis, and down-regulation of the activity of telomerase.
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CHAPTER 1: INTRODUCTION
Interest in dietary bioactive compounds to prevent chronic degenerative diseases and
enhance health arises from evidence supporting a role of these compounds in human health.
Chronic degenerative diseases are of interest because there are no known cure for most of these
diseases and currently available treatments usually only provides a temporary reduction of
symptoms. Breast cancer as a chronic disease is a commonly identified cancer in female in both
economically developed and developing country (Jemal and others 2011). There are various
treatments approaches that have been aimed towards the treatment of the disease but the success
rate of the chemotherapeutic drugs are reported to be low with high rate of recurrence and
various side effects.
Natural compounds or dietary agents have been used as an important tool to treat cancer
because of its low cytotoxicity and less adverse effects. Ginger because of its aroma and taste,
has been used for culinary purposes from ages. It has also been reported in use for medicinal
purpose for more than 2500 years. Ginger is found to be rich of bioactive compounds and
various researches have been carried out to explore the beneficial property of ginger and its
extracts (Grzanna and others 2005; Ali and others 2008; Sharma and others 1994). Essential oils
of ginger are of interest because of its richness in various functional compounds, mostly
terpenes; monoterpenes and sesquiterpenes, which gives the oil its biological activity(Daferera
and others 2002). These bioactive compounds can either remain unmodified or undergo
metabolic transformation into active or inactive derivatives and to fully understand the potential
of ginger oil in human health requires an understanding of the effect of bioactive compounds in
different regulatory mechanism from molecular and cellular level.
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Our aim was to evaluate the effect of oil from ginger against breast cancer. The main
objectives of this study were to:
1) Determine the effect of ginger oil on the viability of breast cancer cells
2) Determine the effect of ginger oil on induction of apoptosis in breast cancer cell
3) Determine the anti-angiogenic activity of ginger oil in vitro using human coronary artery
endothelial cells and hormone-independent breast cancer cells.
4) Determine the effect of ginger oil on the replicative potential of breast cancer cells
5) Determine the effect of ginger oil on expression of various signal transduction molecules
in breast cancer cells
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CHAPTER 2: LITERATURE REVIEW
2.1 Breast Cancer
According to National Cancer Institute at the National Institute of Health, breast cancer is
defined as, “Cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to
the nipple) and lobules (glands that make milk). It occurs in both men and women, although male
breast cancer is rare.” Breast cancer is the leading cause of cancer related mortality in women.
The estimated new cases and death for women in 2010 in the US were 207,090 and 39,840 and
for men were 1,970 and 390 respectively.
The rate of breast cancer in female in developed countries like Northern Europe,
Australia/New Zealand and North America, has been reported to be 2-5 times higher than in
developing countries Asia and sub-Saharan Africa, as shown in figure 2.1 (Jemal et al. 2011).
Some of the major causes of higher incidence of cancer are due to the adopted life-style of
“westernized diets”, lack of physical activity, alcohol, smoking and many others.
Different types of cancer originate from and maintained by a small population of cells
within, which are known as cancer stem cells. They represent less than 5% of the total cancer
cell population and these cells are also the key to breast cancer aggressiveness and lethality. .
Cancer stem cells possess the ability of self-renewal and differentiation. This small population of
cancer stem cells forms a bulk tumor by using several self-renewal and differentiation pathways
and are resistant to chemo- and radiation therapy. Therefore efforts have been made to target
these pathways in order to abolish the recurrence and resistant behavior of cancer stem cells
(Reya and others 2001). Breast cancer stems cells are characterized as CD44+/CD24-/AlDh1+
cells (Charafe-Jauffret and others 2010).
3

Figure 2.1: Incidence and Mortality Rate of Breast Cancer (GLOBOCAN 2008)
Breast cancer can metastasize to lymph nodes and distant organs from the primary site,
which is usually the cause of death. As shown in figure 2.2, the data presented by Lee et al.
suggests that the rate of metastasis of breast cancer cells to organs like lung, liver and bone are
higher than to other different organs (Lee 1983). Various treatment strategies for patients with
breast cancer have been developed like, chemotherapy, radiation therapy, hormonal therapy or
adjuvant therapy that target specific properties of cancer cells. These therapies increases the rate
of survival along with increased long term side effects (Weigelt and others 2005). To progress in
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search for cure of cancer requires understanding of the properties of cancer, which are briefly
explained in section 2.2.

Figure 2.2: Primary breast cancer cells metastasis to various distant organs (Lee 1983).
2.2 Features of Cancer Cells
Most cancer cells have similar characteristics present in a normal cell except that some of
the cells signaling processes are highly up regulated while some of them are heavily down
regulated. Causes of cancer can be inherited through genes or can be adapted due to several
activities like exposure to carcinogens. As biomarkers are defined as molecular, cellular,
functional measurable parameters indicative of a particular genetic, epigenetic or functional
status of a biological system (Ludwig and Weinstein 2005), cancer cell biomarkers, which are
the property of tumor cells can be used for diagnosis, prognosis, staging and treatment.
5

As described by Hanahan and Weinberg, the characteristics of cancer cells can be listed
in six different catagories as described below and also shown in figure 2.2:

Figure 2.3: Six hallmarks of Cancer (Hanahan and Weinberg 2000).
2.2.1 Growth Signals and Cancer
There are various soluble growth factors that are present in a cell, based on which cell
function normally. Normal cells usually recognizes different kind of growth signals and respond
accordingly, but cancer cells do not require those exogenous growth signals and can grow
independent of the signal from the tissue environment. Cancer cells are able to synthesize most
soluble mitogenic growth factors and positively respond to the signals. Some of the growth
factors produced by cancer cells are platelet derived growth factor (PDGF) and tumor growth
factor (TGF). Cancer cell being self-sufficient in growth signal is also explained by higher
6

expression of the receptors. Due to the high level of receptors present in cancer cell, even very
low level of growth factors are detected, which usually would not be recognized in normal cells.
For example in breast cancer cells, epidermal growth factor receptor (EGF-R) and Her2/neu
receptor are overexpressed (Slamon and others 1987).
Normal cells have the property of obeying anti-growth signal whereas cancer cells resist
anti-growth signals. Normally when cells receive anti-growth signal, they get into quescient
stage or permanently lose their ability to proliferate, but cancer cells deregulate this phenomena
by disrupting pRb proteins and mutating various proteins like p15 and p21 because of which the
CDK-cyclin complexes become unresponsive and disregard the anti-growth signals (Zuo and
others 1996).
2.2.2 Apoptosis and Cancer
Apoptosis is also called programmed cell death. It is a normal process that occurs during
development of cell. When stimuli for death are received, cells undergo various morphological
changes and die in a regular and controlled manner. When signals are received by cells, there are
various pathways that are active in order to cause apoptosis. During early phase of apoptosis,
there are families of proteins called caspases that are activated. These groups of proteins create a
cascade that leads to cleavage or change in many structural proteins, nuclear proteins or enzymes
eventually causing cell death.
But in case of cancer, the process of apoptosis is uncontrolled. Cancer cell gain the ability
of escaping apoptosis by mutating tumor suppressor genes like p53, overexpressing apoptoticoncogenes like bcl-2 and c-myc, and inhibiting pro-apoptotic proteins like Bax and cytochromeC.
7

2.2.3 Limitless Replicative Potential
Cancer cell acquire the property of dividing several times that results in uncontrolled cell
growth. The property of uncontrolled cell division and duplication can be defined by two
different processes;
2.2.3.1 Cell Cycle
Cell cycle maintains cell division and growth processes so as to maintain a balance
between cell division and cell death. In a eukaryotic cell, cell cycle is divided into four different
phases: Gap1 (G1) phase or phase for preparation of DNA synthesis, Synthesis (S) phase or the
DNA replication phase, Gap2 (G2) or the preparation for mitosis phase and Mitosis (M) phase or
the dividing phase. The phase other than the M phase is also called the interphase.
DNA of cell can undergo many physical or chemical attacks that can cause its damage.
The source for DNA damage can be extrinsic or intrinsic. Damaged DNA causes cancer. In a
normal cell cycle, cell containing damaged DNA goes through a process called DNA repair,
apoptosis or can halt the progression of cell cycle. For the assurance of this process, various
checkpoints are present in a cell cycle. But in case of cancer, there is deregulation of the cell
cycle process, cell with damaged DNA skip the checkpoints of cell cycle and keep dividing and
replicating (Paulovich and Hartwell 1995).
2.2.3.2 Activity of Telomerase
Telomerase is a reverse transcriptase enzyme responsible for protecting and lengthening
the telomeric ends of DNA. It is normally active only in few types of normal cells like the stem
cells, germ cells and proliferating cells, but its activity has also been recorded in cases of cancer.
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Telomeres are the TTAGGG sequences of DNA that are present at the ends of the
chromosomes. The function of telomere is to maintain the stability of the DNA. With each cell
division, the length of telomeres shortens, and eventually it reaches a limit where the cell is
directed to arrest or senescence. The natural process of telomere shortening is evaded by
activation and up regulation of telomerase, which is found considerably in cancer cells.
Telomerase is found to be very active in 90% of breast cancers and not in normal cells
and therefore is a potential target for both prevention and treatment of breast cancer. Breast
cancer cells have very short telomeres and inhibitors of telomerase can have a significant effect
on further shortening the cells causing growth arrest and cancer (Herbert and others 2001).
2.2.4 Tissue Invasion and Metastasis
Cancer cells are can migrate to distant organs through blood vessels, seed there and grow.
This property of cancer cell is because of their ability of activating various extracellular
proteases like Matrix Metalloproteinase (MMPs) and inhibiting Tissue Inhibitors of
Metalloproteinase (TIMPs), both are very important for tissue remodeling. In a healthy
condition, there is always a balance between MMPs and TIMPs, which prevents the degradation
of extracellular matrix (ECM) proteins. Over expression of MMPs is associated with degradation
of tissues in many chronic inflammatory diseases like cancer. Process of metastasis and tumor
growth is influenced by increase in MMPs activity (Tang and others 2005).
In case of breast cancer cells only MMP-2 and MMP-9 are over expressed, which
belongs to gelatinase group, Gelatinase A and Gelatinase B respectively and are responsible for
tissue invasion, metastasis, and angiogenesis (Joyce and Pollard 2009). Cancer cells are also
capable of altering the binding property of cadherins and cell adhesion molecules. In the
9

process of migrating through the blood vessels they also evade the immune system by release of
immunosuppressive compound. Therefore tissue invading and metastasizing property of cancer
cells can be controlled by targeting the tissue degrading enzymes, inhibiting tumor angiogenesis,
and making tumor cells immune sensitive (Grothey 2005).
2.2.5 Tumor Angiogenesis
Angiogenesis is the process of formation of blood vessels from pre-existing vessels. This
process happens throughout the life starting from the embryo. Angiogenesis helps to recover
different physiological defects in our body, like wound healing, but it can be dangerous too.
There are two types of angiogenesis; Physiological and Pathological.
Cases of pathological angiogenesis can arise due to enhanced or excessive angiogenesis
in the system or due to impaired or decreased rate of angiogenesis. Reduced angiogenesis causes
many non-healing wounds cases like gastric or oral ulcers, diabetic ulcers, impaired bone
fracture healing and cardiovascular diseases like atherosclerosis, diabetes, and restenosis, and
also dented nervous system causing Alzheimer disease, amytropic lateral sclerosis, and diabetic
nephropathy. Some of the other diseases characterized by abnormal angiogenesis are Crohn
disease, osteoporosis, hair loss, kin pupura, telangiectasia, nephropathy, neonatal respiratory
distress, pulmonary fibriosis, and emphysema. On the other hand, high level of angiogenesis
creates many diseases like hemangiomas, cancer, psoriasis, obesity, diabetic retinopathy,
atherosclerosis, asthma, nasal polyps, rheumatoid arthritis, inflammatory bowel disease, and
endometriosis (Dulak 2005).
Basically a tumor cannot grow in size beyond 1-2 mm until it is supplied with nutrients
and oxygen. For a tumor to gain its size and cancerous properties, angiogenesis plays a very
10

critical role. In order to supply itself with nutrients and oxygen, the tumor turns the angiogenic
switch and begins to express growth factors such as vascular endothelial growth factors (VEGF)
promoting formation of blood vessels and directional growth. Therefore, targeting angiogenic
mechanism has been one of the important anti-cancer approaches.

Figure 2.4: Angiogenic switch
2.3 Current Approaches against Breast Cancer Cells and Associated Risks
Breast cancer is a frequently occurring chronic disease that is diagnosed in females.
According to the statistics provided in 2008, breast cancer has been found to cause 23% of the
total cancer worlwide and 14% of the cases has been reported to cause death (Jemal et al. 2011).
Various treatment approaches have been designed to eradicate breast cancer, which are listed
below;


Surgery



Medicine
11

o Monoclonal antibodies
o Chemotherapeutic drugs
o Hormonal Therapy


Radiation



Preventive chemotherapy



Dietary approaches

2.3.1 Drugs against Breast Cancer
There are various drugs that have been introduced to treat breast cancer. The problem
related with the drugs provided is, their side effects to non-tumoral tissues. Some of them are
listed below (Pegram and others 2004; Cuzick and others 2011):
 4-hydroxycyclo phospamide

 Gemcitacbine

 Carboplatin

 Anastrazole

 Docetaxel

 Letrozole

 Paclitaxel

 Tamoxifen

 Vinorelbine

 Raloxifen

 Epirubicin

 Trastuzumab

 Doxorubicin
Table 2.1: Some of the side effects associated with mode of treatment
Radiation therapy

Chemotherapy

Hormonal therapy

Lymphodema

Hair loss

Stroke

Fractures of breast bone

Nausea, vomiting

Blood clots

Pain in heart muscles

Anemia

Uterine cancer
12

(Table 2.1 continued)
Radiation pneumonitis

Joint pain

Effect on heart

Change of taste

Risk of cancer

Fatigues

Swelling of breast

Weight gain

Fatigue

Cognitive dysfunction

Cardiac weakness

Peripheral neuropathy

Menstrual problems

Heart failure
Leukemia

2.4 Functional Foods and Cancer
Functional foods are foods containing physiologically-active components, which provide
health benefits beside nutrition, when consumed on a regular basis (Hasler 1996). The Institute
of Medicine's Food and Nutrition Board (IOM/FNB, 1994) has defined functional foods as "any
food or food ingredient that may provide a health benefit beyond the traditional nutrients it
contains" Dietary agents contain many bioactive compounds in them and had been effectively
used as a source of traditional medicine. Profound interest in health-benefiting foods have
initiated various research to recognize activity of functional foods against different chronic
degenerative diseases like, cancer, heart disease, osteoporosis, arthritis, age related diseases and
many other. This correlates with what Hippocrates said 2500 years ago as, “Let food be thy
medicine and medicine be thy food”. Epidemiological studies focusing on the mechanism of
functional food against cancer have demonstrated that consumption of fruits and vegetables
causes reduced risk of various cancers (Rafter 2002).
13

Figure 2.5: Molecular targets of cell cycle regulation in cancer cells in vitro and in vivo by
dietary agents. Upward arrows (↑) indicate enhancement, and downward arrows (↓)
indicate a reduction in the levels, or inhibition of the activity of the target
molecules(Meeran and Katiyar 2008).

Table 2.2: Dietary Agents against Cancer Stem Cells (Li and others )
Natural dietary
compound
Curcumin

Food origin

CSC

Turmeric

Breast CSCs

Sulforaphane

Cruciferous
vegetables
Soy

Pancreatic CSCs,
breast CSCs

Soy isoflavone
(especially genistein)
Epigallocatechin-3gallate
Resveratrol
Lycopene

Piperine
Vitamin D3

Green tea
Grapes, berries,
plums, and peanuts
Tomatoes,
watermelon, papaya,
pink grapefruit
Black and long pepper Breast CSCs
Fish, egg yolk, beef
liver
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Elements of selfrenewal pathways
β-catenin, TCF-4,
Frizzled-1; Notch-1
β-catenin, GSK3β (?),
Wnt-9a
GSK3β, β-catenin,
Wnt-5a, Sfrp-2;
Notch-2
HBP1, β-catenin
β-catenin, GSK3β;
Notch-1
β-catenin
Wnt/β-catenin
TCF-4, E-cadherin

2.5 Ginger
Zingiber officinale belongs to the family Zingiberaceae (Park and Pezzuto 2002). It
originated in South-East Asia and now is well known around the world. Ginger plant is an
herbaceous, rhizomatous, perennial plant, which is usually 2-3 feet tall and is found naturally in
tropical and sub-tropical region. The rhizome part of the plant or the ginger is an aromatic, pale
yellowish, thick lobed structure and possesses a pungent smell. Ginger is commonly used as a
flavoring agent in food. It is usually used as a fresh paste, or in dried form or in slices. It has also
been used in cosmetic and medicinal purposes and used as a herbal medicine in Ayurvedic and
Chinese tradition (Ali et al. 2008). It is reported to be rich in anti-oxidant content and has been
used as a medicine from ancient time as back as 2500 years (Grant and Lutz 2000).
Table: 2.3 Molecular Target of Ginger in Cancer (Aggarwal and Shishodia 2006)
Name

Active compound

Molecular Target

Ginger (Zingiber officinale)

Gingerol

↓TNF, ↓NFK-B, ↓AP-1,

Paradol

↓COX-2, ↓ODC, ↓iNOS,
↓p38MAPK, ↓HIF, ↓VEGF,
↑caspase-3, ↓Bcl2

Ginger possesses its health-enhancing property because of the presence of the pungent
compounds and the volatile compounds. The odor of the ginger is mainly due to the essential oil
present (Ali et al. 2008). Gingerols, shogaols and paradols are some of the pungent compounds
and terpenes and sequiterpenes are the volatile ones. Ginger has found to be effective against
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Figure 2.6: Non-Volatile Pungent Components of Ginger (Shukla and Singh 2007)
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many diseases like arthritis, urinary infections, gastrointestinal disorders and pain. It is also an
effective antiviral and antimicrobial agent and has potential to reduce diabetes mellitus,
cardiovascular and gastric disorders (Shukla and Singh 2007).
Hsu et al. have also demonstrated 6-dehydrogingerdione (DGE) as a major component of
ginger that has its effect against breast cancer. It was found that DGE activated caspase, up
regulated p21 level and down regulated cyclin B1, cyclin A, Cdc2, Cdc25C and thus arrested
cells at G2/M phase and caused apoptosis (Hsu and others 2010). 6-gingerol, another component
of ginger has been found to have negative effect on NF-κB activation, cell proliferation, and
angiogenesis (Kim and others 2005) and also arrests cell cycle at G1 phase by downregulating
cyclin D1 (Ippoushi and others 2003).
2.6 Ginger Oil
Ginger contains 9% of lipids or glycolipids and 5-8% of oleoresin (Chrubasik and others
2005). The percentage of essential oil in ginger is 3%. Essential oils are also called volatile oil or
ethereal oil and are the aromatic oily part that is usually obtained from various parts of plants
like flowers, buds, seeds, leaves, stem, bark, herbs, twigs, fruits or roots. Oils from plant have
been used as a traditional medicine from ages. According to Food and Drug Administration,
ginger essential oil has been regarded as a GRAS (Generally Recognized as Safe) product under
the Code of Federal Regulation (CFR) parts; 182.10 and 182.20.
Aromatic plants contain terpenes; mostly monoterpenes and sesquiterpenes, which
provide them their biological property. Terpenes have very good property of penetration because
of which they have been used as drug penetration enhancers (Aqil and others 2007). The factors
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that contribute to permeation capability of terpenes are its lipophilicity, size and chirality, degree
of unsaturation, boiling point, and energy of vaporization.
Sesquiterpenes are the abundant one in the volatile oil of ginger, and consists of
zingiberene, curcumene, farnesene, b-sesquiphenalbrene, and bisabolene. The flavor and taste of
ginger is derived from the volatile components in it (Shukla and Singh 2007).
Studies have been carried out to evaluate the composition of ginger oil. Lawrence et al.
found 114 compounds in the volatile oil of ginger (Lawrence 1984). Nogueira de Melo et al.
have found curcumene, beta-mycrene, 1,8-cineol, citral and zingiberene as the major component
of ginger oil (Nogueira de Melo and others 2011).
Anti-inflammatory, antinociceptive, and immunomodulatory properties of ginger oil has
been demonstrated by Nogueira de Melo (Nogueira de Melo et al. 2011). The experiment
carried out by Sharma et al on arthritic rats has suggested that ginger oil contains anti-rheumatic
and anti-inflammatory properties (Sharma et al. 1994).
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Table 2.4: Classification of Terpenes on Basis of Isoprene Units
Number of isoprene units (C5H8)n

Types of terpenes

C10H16

Monoterpenes

C15H24

Sesquiterpenes

C20H32

Diterpenes

C25H40

Sesterterpenes

C30H48

Triterpenes

C40H64

Tetraterpenes

Table 2.5: Classification of Terpenes on Basis of Their Chemical Composition
Class

Example

Alcohols

Linalool, geraniol

Esters and alcohols

Linalool, linalyl acetate, menthol, menthyl
acetate

Aldehydes

Cinnamaic aldehyde, cinnamic aldehyde

Ketones

Carvone, thujone

Phenols

Eugenol, thymol

Ethers

Anethole, cineole

Peroxides

Ascaridole
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CHAPTER 3: MATERIALS AND METHODS
3.1 Ginger Oil (GO)
To carry out this research, commercially available ginger oil was purchased from Sigma
Aldrich. According to the data provided, the oil was all natural, kosher, halal grade and obtained
by steam distillation. Zingiber officionale roscoe of China origin was the source of the oil and it
could be tasted in concentration as low as 30 ppm. The boiling point of the oil was listed as
254oC and density as 0.871g/ml at 25oC.
3.2 Cell Cultures
In this study, hormone independent MDA-MB-231(HTB-26) human breast cancer cells,
which are ER-, p53 mutated and a model of more advanced stage breast cancer (Hsu et al. 2010)
were used to model the molecular mechanism for the inhibitory effect of ginger oil against
cancer.
The cell line gets its name from M.D. Anderson-Metastatic Breast- 231. The cell line was
obtained from American Type Culture Collection (ATCC) (Rockville, MD). MDA-MB-231 is an
epithelial adenocarcinoma cells isolated from the breast of Homo sapiens and have adherent
growth properties. They were sub-cultured as a mono-layer according to the instructions
provided by ATCC.
The MDA-MB-231 human breast cancer cell line was maintained in Dubecco’s Modified
Eagle’s Medium (DMEM) containing 10% of fetal bovine serum (FBS), 15mM HEPES, and
non-essential amino acids. Cell propagation media was purchased from Invitrogen (Carlsbad,
CA).
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Figure 3.1: Morphology of MDA-MB-231 Cells
3.3 Gas Chromatography-Mass Spectrometric (GC-MS) Analysis of Ginger Oil
Gas Chromatographic analysis was performed with a Leco TOF GC/MS system equipped
with an Agilent 6890 GC, under the following conditions: DB-5 capillar column (30 m X
0.25mm, 0.25 μm) (J &W Scientific, Albany, NY) was used with a flow rate of 1.0 mL/min.
Ginger oil was diluted 1:10 with dichloromethane. One microliter injections were made in
splitless mode at an injection temperature of 300 °C. The GC oven was initially held at 50 ºC for
one minute then increased at 3 ºC/min to 80 °C and then at a rate of 10 °C/min to 340 °C. Data
was collected from m/z 35 to m/z 1000 at 20 spectra per second.
3.4 Cell Viability Assay
3.4.1 MTS Cell Proliferation Assay
Breast cancer cells (5x103 per well) were seeded on 96-well plates. The cells were grown
for 24 h prior to treatment. Ginger Oil was mixed with dimethylsulfoxide in a ratio of 3:1 and
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ginger oil at concentration of 0.05%, 0.1%, 0.15% or 0.2% of the total volume of the media used
were added to the cells. The cells were incubated for 24, 48 and 72 hours at 37oC in an incubator
with 5% CO2. After incubation, cells were treated with the MTS reagent according to the
protocol provided by the supplier, CellTiter 96 AQueous One solution (Promega, Madison, WI).
The number of viable cells was directly proportional to the absorbance at 490 nm due to the
reduction of formazan product from MTS. Absorbance was read in a BioRad Model 680 micro
plate reader (Hercules, CA). Cell viability was presented in terms of percentage of control. The
experiment was performed in triplicates.
3.4.2 Caspase Assay for Apoptosis
After performing cell viability assay, caspase assay was performed in order to determine
the activity of caspase in the cells treated with ginger oil. Breast cancer cells MDA-MB-231,
5X103 cells were seeded in a 96 well plate and after 24 h cells were treated with vehicle
(DMSO), ginger oil at concentration of 0.05% or 0.1% of the total volume of the media used.
The plate was incubated for 72 hours and caspase-9 assay was performed using the Caspase-Glo
9RM (Promega, Madison, Wisconsin). After incubation, luminescence was measured using, The
Reporter™ Microplate Luminometer. Results were presented in terms of percentage of control.
Each experiment was performed in triplicate.
3.5 Cell Cycle Analysis
Breast cancer, MDA-MB-231, 0.5x106 cells were grown on T-25 flasks and were treated
with vehicle and ginger oil at concentration of 0.05%, 0.1%, 0.15% or 0.2% of the total volume
of the media used. After 72 hours of incubation, cells were trypsinized and suspended in PBS
and counted using trypan blue. Cells (2x105) were selected and centrifuged at 1000 rpm (200g)
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for ten minute at room temperature. The supernatant was discarded and the cells were resuspended in 100ul of PBS and 900ul of 95% cold methanol. Methanol was added drop by drop
to the pellet; the cells were vortexed and incubated for 30 min at 4oC.
After incubation cells were centrifuged at 2000 rpm for 5 min at room temperature. Then
methanol was removed making sure not to lose cells. After that cells were suspended in 450µl
Phosphate Buffer Saline (PBS) (Santa Cruz Biotechnology, Santa Cruz, CA), 25µl RNAse
(Roche Diagnostics, Indianapolis, IN) (500 µg/ml) and 25µl Propidium Iodide (Sigma-Aldrich,
St. Louis, MO) (1mg/ml). The samples were incubated in dark for 24 hours and flow cytometric
analysis was performed using Beckman-Coulter Epics flow cytometer using CXP software.
3.6 In Vitro Angiogenesis
The assay was performed using the in vitro angiogenesis assay kit from MilliporeTM. Following
the preparation of ECMatrixTM using the manufacturer’s instructions, 7.5 x 103 human coronary
artery endothelial cells (HCAECs) were seeded on the surface along with the 150ul supernatant
from the untreated MDA-MB-231 cells and cells treated with 0.05% and 0.1% ginger oil. The
cells were then incubated at 37oC for 6 hours and tube formation was analyzed and photographed
using a Leitz phase-contrast inverted microscope at 10X magnification.
3.7 Telomerase Activity
Telomerase is the enzyme responsible for adding the telomeric repeats at the end of DNA
sequence. Its activity has been reported in immortal cells, cancer cells and germ cells.
Telomerase activity in the samples was measured using a PCR based assay (TRAPEZE® XL
Telomerase Detection Kit, MilliporeTM, Billerica, MA). MDA-MB-231 cells were first treated
with ginger oil at concentration of 0.05% and 0.1% of the total volume of media used. After 72 h
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of incubation, cells were lysed with CHAPS lysis buffer provided in the kit to extract the protein.
Protein concentration determination of the lysate was done by Bradford method using BSA as
standard. The concentration of the protein of the samples used for detection of telomerase was
made to 750ng/µl. And then the protein samples were then combined with TRAPeze reagents to
perform PCR. Manufacturer’s instruction was used for making the standards provided in the kit.
As telomerase is a heat sensitive enzyme, negative telomerase samples were also
prepared by heat treating them at 85oC for ten minutes. The primer provided in the kit is
Ampifluor® primers that only glow after incorporation. After running the PCR, to quantitate
telomerase activity, fluorescein and sulforhodamine emission detection was done using
Cytofluor® Multi-well Plate Reader (PerSeptive Biosystems, Framingham, MA). The excitation
and emission filters for fluorescein detection was at 485nm and 535nm respectively. While for
sulforhodamine detection, the excitation and emission filter was at 585 nm and 620 nm
respectively. The reading was taken using fluorometer. The results were expressed in terms of
percentage of control. The experiment was done in triplicates.
3.8 Western Blot Analysis of Biomarkers
MDA-MB-231 cells were incubated with varying concentration of ginger oil, 0.05% and
0.1% of the volume of media for 72 hours. Cells were then washed with Phosphate Buffered
Saline (PBS), lysed in radioimmunoprecipitation assay buffer (RIPA) supplemented with
protease inhibitor, sodium orthovanadate and phenylmethanesulfonylfluoride (PMSF). After 30
min incubation on ice with the lysis buffer, cells were centrifuged at 14,000 rpm for 10 min, and
the supernatant was saved; protein concentration was determined by the Bicinchoninic acid
(BCA) method using BCA protein Assay Reagents (Thermo Scientific, Rockford, IL). Equal
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amounts (1000 μg) of total cell extract protein from control and GO treated cells were mixed
with LDS sample buffer (Invitrogen, Carlsbad, CA), brought to desired volume with water,
boiled for 3 minutes centrifuged at high speed for 30 sec, and loaded onto SDS polyacrylamide
gels; 4-12% Bis-Tris gels or 3-8% Tris-acetate gels (Invitrogen, Carlsbad, CA) depending on the
size of the protein.
Proteins of interest were then separated and transferred to polyvinylidene difluoride
(PVDF) membranes (Invitrogen, Carlsbad, CA). Membranes were blocked with 5% Bovine
Serum Albumin (BSA) in Tris Buffer Saline (TBS) containing 0.05% Tween 20 (TBS-Tween)
for 1h. The PVDF membranes were incubated with primary antibody in TBS-Tween containing
5% BSA overnight at 4 ºC with gentle agitation following the manufacturer’s instructions.
Visualization of the bound primary antibody was done by probing with alkaline phosphatase–
conjugated secondary antibodies and exposure to chromogenic detection reagent BCIP
(Invitrogen, Carlsbad, CA).
Primary antibodies like NF-κB, Cadherin E, Bax, Bcl2, CD44, ESA, Aldh1, VEGF,
cathepsin D and the alkaline phosphatase- conjugated secondary antibody was purchased from
Santa Cruz Bitechnology® (Santa Cruz, CA). Other primary antibodies like Hsp90, PDGFR-β, pIGF-1R, Her2, pERK, Histone, phospho-p38 was purchased from Cell Signaling Technology®
(Danver, MA).
3.9 Interleukin-8 (IL-8) and Tumor Necrosis Factor-α (TNF-α) Levels in MDA-MB-231
Cell Supernatants
To determine the effect of inhibition by GO on IL-6, IL-8 and TNF-α expression, we
measured their levels in the supernatants of vehicle, 0.05% and 0.1% GO treated cells by ELISA
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using commercial kits from Prepotech (Rocky Hill, NJ). Manufacturer instructions were used
and the test was done in triplicate and results were expressed in percentage of control.
3.10 Statistical Analysis
Results are expressed as means ± SD of experiments each conducted in triplicate.
Statistical analysis was conducted using the Statistical Analysis Software (SAS) (version 9.2).
Analysis of variance (ANOVA) was conducted to examine the differences between treatments
followed by Tukey analysis. A P-value of < 0.05 was considered to be statistically significant.
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CHAPTER 4: RESULTS AND DISCUSSION
4.1 GC-MS Analysis of Ginger Oil
To determine the components of the ginger oil GC-MS analysis of the oil was done.
Trace level of compound present were detected and all of those compounds are presented in
Table 4.1. Among those many compounds present in ginger oil, the major compounds were
eucalyptol (14.2%), cuparene (12.3%), bicycloheptane (11.4%), γ-muurolene (10%), α-farnesene
(8%), α-pinene (4%), and β-myrcene (2.2%). However the level of zingiberene, curcumene and
citral were found to be as low as 0.7%, 0.2% and 0.4%, which contrasts with the findings of
Nogueira de Melo et al., who had reported ar-curcumene, beta-mycrene, 1,8-cineol, citral and
zingiberene as the major component (Nogueira de Melo et al. 2011).
The effect of sesquiterpenes has been studied in many tumor cell lines. Cadinol and γmuurolene exhibit anti-cancer effect on colon cancer and breast cancer cells (Chang and others
2000). And the results from GC-MS analysis shows that ginger oil contains both cadinol, γmuurolene at concentrations of 0.1% and 10.9% respectively. Elmene, which is also one of the
components found in ginger oil, also has been studied for its anti-tumor activity in leukemia
cells. The results found from the study by Yang suggest that elmene is effective in inducing
apoptosis, which gives property of anti-tumor activity to it (Yang and others 1996)
Essential oils from berries, Schinus molle L. and Schinus terebinliflious have been shown
to have anti-cancer properties against breast cancer cells (Bendaoud and others 2010), and some
of the compounds of the oil were similar to the one found in ginger oil like, germacrene D,
terpinoid, phellandrene, pinene, cymene, terpineol, and α-himachalene. This suggests that
properties of ginger oil against cancer are due to the presence of all these bioactive molecules.
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Table 4.1: GC-MS Analysis of Ginger Oil
Compound
1,7,7-Trimethyltricyclo[2.2.1.0
(2,6)]heptane
α-Pinene
Bicyclo[4.1.0]heptane, 7-(1-methyl
ethylidene)β-Pinene
β-Myrcene
l-Phellandrene
Eucalyptol
α-terpinolene
3-Methyl-2-(2-methyl-2-butenyl)furan
Linalool
m,/z 168 Me Borneol Ether
m/z 136 & 154 Terpenoid
Camphor
exo-methyl-camphenilol
Rose furan epoxide
1-borneol

Percentage
%
0.2

Compound

Percentage
%
0.2

4.0
11.4

6-Octen-1-ol, 3,7dimethyl-, acetate
Cyclohexene
α-Copaene

0.4
2.2
0.9
14.2
0.4
0.5

β-Elemene
Zingiberene
Germacrene D
Germacrene B
β-Sesquiphellandrene
neoalloocimene

1.9
0.7
0.6
2.1
2.0
0.6

0.8
0.2
0.1
0.1
0.1
0.5
1.7

(R)-Cuparene
α-Farnesene
alpha-Himachalene
γ-Muurolene
α-Farnesene
Camphogen
Sesquisabinene
hydrate
α-curcumene
Zingiberenol
α-Gurjunene
Bicyclogermacrene
τ-Cadinol
β-Eudesmol
α-cedrane
Mint sulfide
Nerol

12.3
8.0
4.8
10.9
2.5
0.2
0.8

4-Terpineol
α-Terpineol
n-Decanal
β-Citronellol
Z-Citral
GERANIOL
E-Citral
l-Bornyl acetate
2-Undecanone

0.2
1.1
0.3
0.3
0.2
0.5
0.4
0.3
0.4

α-Elemene

0.2
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1.2
0.9

0.2
1.1
1.0
0.6
0.1
1.9
0.9
0.3
0.3

4.2 Effect of Ginger Oil on Cell Viability
To determine the number of viable cells after the treatment with ginger oil, cell
proliferation assay was performed using CellTiter96® Aqueous from Promega (Madison,
Wisconsin). The assay is based on the colorimetric principle to determine the number of viable
cells. After adding MTT reagent into the cells, formazan product is formed from the tetrazolium
salt containing MTT reagent. The formazan is an aqueous soluble, colored product formed from
the mitochondrial activity of the viable cells and is read at 492 nm. The absorbance at 492 nm is
directly proportional to the number of viable cell present (Malich and others 1997). This assay
has been used to quantitate cell proliferation and survival of living mammalian cells (Mosmann
1983).
To investigate the effect of ginger oil on the growth of MDA-MB-231 breast cancer cells,
cells were incubated for 24h, 48h and 72h with 0.05%, 0.1%, 0.15%, and 0.2% of ginger oil with
respect to the volume of media used for cell growth. Cell proliferation was then measured at
490nm using MTS assay. As shown in figure 4.1, cell growth was reduced only by 1%, 5%, 9%,
and 26% in the cell treated with 0.05%, 0.1%, 0.15%, and 0.2% of ginger oil for 24 h. But after
48 h, cell growth was reduced by 20%, 26%, 40%, 60% in terms of 100% of control with 0.05%,
0.1%, 0.15% of ginger oil and 72 h of incubation caused reduction of 52%, 61%, 66%, and 73%
Literatures suggest that [6]-gingerol, one of the major compounds of ginger is able to
inhibit growth and proliferation of colon cancer cells at a concentration of 100µM/L (Jeong and
others 2009). Other group of study has shown that after 72 h incubation of [6]-gingerol in
colorectal cancer cell, the rate of cell growth was reduced by 22% and 28% with 150µM and
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200µM [6]-gingerol respectively. The growth was also reduced in CaCo2 and HT-29 cells by 8
and 28% respectively (Lee and others 2008).
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Figure 4.1: Effect of Ginger oil on the viability of MDA-MB-231 cells with respect to time and
concentration. Values (means ± SD, n=3) not sharing common letters, ABCDE are
significantly different (α=0.05).
4.3 Effect of Ginger Oil on the Activity of Caspase for Apoptosis
To further evaluate the cause of apoptosis, caspase assay was performed by determining
the caspase activity on the cells with vehicle and ginger oil treated cells, Caspase-Glo®-9 Assay
from Promega was used. Caspases are group of proteases that plays a very important role in the
process of apoptosis in mammalian cells. This caspase assay is a luminogenic assay that
measures the caspase activity. The reagent provided includes substrates for caspase activity,
luciferase activity, and cell lysis. The cell lysis causes the caspase to release and then break the
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substrate; this cleavage causes the release of glow, which is measured as a luminescent signal.
The amount of luminescence is directly proportional to the activity of caspase in the system.
As shown in figure 4.3, our results demonstrated that the activity of caspase in the cells
treated with ginger oil was higher than in control. In case of the cells treated with 0.1% ginger oil
the level of caspase activity was significantly increased as high as 136% more than the control.
Activated caspases can cleave various intracellular proteins, protein kinases, molecules
for DNA repair and many components of nucleus and cytoplasm. This process leads to
interference of the survival pathways and creates many morphological and biological changes,
which causes apoptotic cell death (Earnshaw and others 1999).

Figure 4.2: Pathway of Caspase Activation.(Nunez and others 1998)
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Among various caspases, caspase8, caspase9, and caspase10 act as an initiator caspase
that can trigger the activation of different other caspases. Caspase 9 is a type of caspase that is
activated by mitochondrial initiated pathway. This creates a series of caspase cascade that
ultimately destroys cell (Chen and Wang 2002). This caspase is responsible for a chain of
caspase cascades. It activates downstream caspases like caspase -3, -6 and -7 (Budihardjo and
others 1999).
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Figure 4.3: Dose Dependent Effect of Ginger Oil on the Activity of Caspase9. Values (means ±
SD, n=3) not sharing common letters, ABC are significantly different (α=0.05).
4.4 Ginger Oil Modifies Breast Cancer Cell Cycle Progression and Cell Cycle Regulatory
Protein Expression
To determine the effect of ginger oil on the cell cycle and to confirm apoptosis, cell cycle
analysis of the cells treated with vehicle and 0.05% or 0.1% of ginger oil was done by flow
cytometry. As shown in figure 4.4, the data demonstrated that ginger oil induced apoptosis and
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sub-G1 phase formation in MDA-MB-231 breast cancer cells. The results from cell cycle
analysis showed that ginger oil treatment resulted in the increase of sub-G1 phase. The
percentage of the cells in sub G1 phase of the vehicle was 1.83% and in those treated with 0.05%
or 0.1% of ginger oil was 14.80% and 69.19% respectively.
During apoptosis, the DNA of the cell undergoes degradation due to many enzymes. To
analysis this phenomenon, DNA analysis can be done. The sub G1 phase of the cell cycle
provides the percentage of those cells with damaged DNA. When the cell loses the DNA, the cell
stains less and then appears at the left side of the G1 phase, that is why it is called the sub-G1
phase (Kajstura and others 2007).
Cell cycle analysis also demonstrated that ginger oil treatment resulted in an increase of
the G2 phase and S phase. G2 phase of the cycle showed that the control had 15.98% cells,
0.05% GO treated cells had 20.86% cells, and 0.1% GO treated cells had 17.68% cells. The S
phase and decrease of the G1 phase of the cell cycle in MDA-MB-231 cells. Ginger oil increased
the cell cycle arrest at G2 and S phase.
To determine the level of cell cycle regulatory proteins, western blot analysis of some of
those proteins was done. Cyclin dependent kinase and cyclin proteins; Cyclin D1, CDK-4, and
CDK-2 proteins were analyzed. Cyclin dependent kinase and cyclin are responsible for the
transition from G1 to S phase. As shown in figure 4.4, ginger oil effectively decreased the
expression of cyclin D1, CDK4 and CDK2 required for G1 progression.
Cyclin dependent kinase (CDK) and cyclin proteins are the one responsible for the
transition from G1 to S phase. Cell cycle is regulated by the phenomena of activation and
deactivation of these CDK and cyclin complexes. There are elven different kinds of CDKs
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identified in cells of mammals, which are CDK1-CDK11, but only CDK2, CDK3, CDK4, and
CDK6 make a complex with G1 cyclins and are responsible for the transition from G1 phase to
the S phase. Checkpoint proteins checks for DNA damage, causes cell cycle arrest, and sends
signals to the other cascade mechanisms like cell cycle repair or apoptosis. Dysregulation of the
checkpoint process in a cell may result in cardiovascular diseases, neurodegenearative disorders,
cancer, and many others.
CDK4 and CDK6 are activated during mid G1 phase and complexes with cyclin D while,
CDK2 complexes with cyclin E and cyclin A during late G1 phase (Morgan 1997). CDK2 has
also been reported as a potential target for treatment of breast cancer at early stage. Cyclin Ds in
the G1 phase are activated as soon as cells enter the cell cycle, and the complex passes signals
for mitogenic pathways. Cyclin D1 independent of CDKs also interacts with histone acetylase
and other transcription factors (Diehl and others 1998). Cyclin E controls the beginning of DNA
replication and the CDK2/cyclinE complex also prompts the duplication of centrosomes. Cyclin
E is found to be overexpressed in cases of lungs cancer and breast cancer. Cyclin A assists in
assembling the components for DNA synthesis and hence activates the S phase and at the same
time it also makes sure that no other new complexes are assembled so it assures G1 phase has
ended before the beginning of the S phase (Coverley and others 2002).
Besides triggering the mechanism for repairing DNA damage, CDK-cyclin complexes
are also supposed to maintain or regulate the length of telomeres and structure of chromatin,
controlling transcription of DNA repairing genes, arranging cytoskeleton and staffing repairing
proteins to the site. If the checkpoints fail to detect the damage, it may lead to various
abnormalities like mutation, aneuploidy and chromosome instability, which eventually leads or
causes tumorigenesis (Hartwell and Kastan 1994).
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Figure 4.4: Cell Cycle Analysis of A: Control cells, B: Cells Treated with 0.05% GO, C: Cells
Treated with 0.1% GO, D: Western Blot Analysis of Cell Cycle Proteins.
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4.5 Effect of Ginger Oil on Tumor Necrosis Factor-α (TNF-α) Levels
To determine the level of TNF-α expression in the treated cells ELISA was done. TNFα, a pro-inflammatory cytokine is a peptide hormone that effects death of tumor cells,
inflammation and immune response. Our in vitro experiments show that ginger oil can inhibit the
proliferation of MDA-MB-231 breast carcinoma cells. As shown in figure 4.5, ginger oil can
significantly inhibit the expression of TNF-α at concentrations of 0.05% and 0.1%.
TNF-α was primarily discovered as a molecule responsible for antitumor activity, but
recent studies have proved that this molecule facilitates tumor initiation, promotion, and
metastasis. Increase in TNF-α level increase the property of tissue invasion and metastasis
through the up regulation of NF-κB pathway (Hagemann and others 2005). TNF- α secreted by
tumors induce the secretion of matrix metalloproteases (MMPs) that help in the process of
invasion and metastasis, and also increases the production of VEGF (Szlosarek and Balkwill
2003). Inflammation is one of the major properties required for promotion of tumor. Among all
the cytokines responsible for cell-cell communication, TNF- α is a major one. The
proinflammatory effect of TNF- α is primarily because of its capability to activate NF-κB, which
further causes expression of many inflammatory genes.
Hanahan and Weinberg have classified cancer with six different major hallmarks and
they have also reported that chronic inflammation is caused by the dysregulation of TNF- α
production. TNF-α promotes carcinogenesis by influencing all six hallmarks of cancer. It does so
by activating reactive oxygen intermediates (ROIs) that in turn activates telomerase giving it
limitless replicative potential, by up regulating inflammatory enzyme like; nitric oxide synthase,
cyclo-oxygenase, by triggering the production of matrix metalloproteases responsible for

36

invasion and metastasis, and by activating many other cytokines and cell adhesion molecules
(Hanahan and Weinberg 2000; Szlosarek and others 2006).
TNF- α is found to be a growth factor for most of the tumors including breast cancer. As
TNF can mediate so many pathways for carcinogenesis, it has been a potential target for therapy
against various chronic diseases. Various dietary phytochemical agents have been reported to
decrease the level of TNF- α expression; curcumin, green tea polyphenols, resveratrol,
kaempferol, apigenin, and gingerol (Yang and others 1998; Surh and others 1999; Kowalski and
others 2005).
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Figure 4.5: Effect of Ginger Oil on the Expression of TNF-α. Values (means ± SD, n=3) not
sharing common letters, ABC are significantly different (α=0.05).
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4.6 Inhibition of Telomerase Activity
Telomerase are found to be active in cancer cells and dormant in normal cells.
Telomerase gives cancer cells its property of immortality. Also high telomerase activity
correlates with high malignancy and aggressive nature of cancer. Therefore telomerase has been
a potential target against cancer. As shown in figure 4.6, we have demonstrated that ginger oil at
concentrations of 0.05% and 0.1% could significantly inhibit telomerase expression by 21 % and
49% respectively in compare with the control.
Researches have shown that ethyl acetate extraction of ginger down regulates the
expression of human telomerase reverse transcriptase (hTERT) gene eventually decreasing the
level of telomerase in lung cancer cells (Tuntiwechapikul and others 2010). Some of the other
sources of dietary agents that have been able to inhibit telomerase are polyunsaturated fatty acids
like eicosapentanoeic acid and docosahexaenoic acid(Eitsuka and others 2005), epigallocatechin
gallate from green tea (Naasani and others 2003), sulfoquniovosyldiacylglycerol from plants and
seaweed (Eitsuka and others 2004), sulforaphane from broccoli (Moon and others 2010).
4.7 Effect of Ginger oil on Expression of Various Signal Transduction Molecules
To determine the effect of ginger oil on different signal transduction pathways,
expression of proteins that are over expressed in case of breast cancer were investigated. There
are various signaling proteins that are activated for the proliferation and anti-apoptotic property
of cancer cells. Therefore molecules that are involved in different processes of cell regulation
were investigated in this study using western blot and ELISA, and the obtained results are
presented below.
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Figure 4.6: Effect of Ginger Oil on the Activity of Telomerase. Values (means ± SD, n=3) not
sharing a common letters, ABC are significantly different (α=0.05).
4.7.1 Effect of Ginger Oil on Expression of Oncogenic Proteins
4.7.1.1 Nuclear Factor-KappaB (NF-κB)
Expression of NF-κB supports the cell to proliferate and survive however down regulation
of this protein molecule directs cell towards apoptosis (Aggarwal and others 2004). As shown in
figure 4.7, the results from the western blots show that there was down regulation of NF-κB by
ginger oil at concentrations, 0.05% and 0.1%. This can also be supported by the findings of
Aggarwal that gingerol from ginger down regulates NF-κB pathway (Aggarwal and Shishodia
2006). Some of the genes that regulate NF-κB are bcl-2, survivin, TRAF 1 and TRAF 2 and they
act by blocking the apoptotic process so these genes and proteins are highly expressed in cancer
(Aggarwal and Shishodia 2004). The treatment of cancer cells with ginger oil also showed to
decrease the expression of apoptosis suppressor proteins like Bcl-2.
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High activity of NF-κB activity is also associated with high level of VEGF mRNA
expression, which means that inhibition of NF-κB, should lead to inhibition of VEGF production
(Shibata and others 2002). Our results (Figure 4.12) also demonstrate that cells treated with
ginger oil shows significant decrease in VEGF levels.
4.7.1.2 Heat Shock Protein 90 (Hsp90)
Heat shock response is a very important property that cancer cells possess and Hsp90 is
one of the very important molecular chaperones involved in this response. Hsp90 is a master
regulator that gives activity and stability to many oncoproteins like Her2, many kinases and
transcription factors. It is overexpressed in cancer cells and in case of breast cancer; it is
associated with decreased survival (Pick and others 2007). Oncoproteins undergo several
mutations and this phenomenon makes them resistant to inhibitors and for cases like this,
targeting Hsp90 might be a useful solution as many oncoproteins depend on Hsp90 to maintain
their oncogenic property and mutations (Porter and others 2010).
As shown in figure 4.7, we could demonstrate that Hsp90 expression level was reduced in
cells that were treated with ginger oil at concentrations of 0.05% and 0.1%. The reduction was
from 15% to 18% compared to the control.
4.7.1.3 E Cadherin
Cadherins are the calcium ions dependent transmembrane glycoproteins responsible for
cell adhesion. Breast E Cadherin is expressed in normal epithelial cells of breast and the reduced
expression of E cadherin has been found to induce the property of invasion and metastasis in
breast cancer (Oka and others 1993; Siitonen and others 1996). As shown in figure 4.7, E
cadherin was expressed in the cells treated with ginger oil.
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Figure 4.7: Expression of Oncogenic Proteins
4.7.2

Effect of Ginger Oil on Expression of Growth Factor Receptors
In case of pathological conditions like cancer, growth factors are highly expressed. This

makes cancer cell very sensitive even to very a lesser amount of growth signals. As shown in
figure 4.8, the expression of PDGFR-β, p-IGF-1R or Her2 was highly down-regulated in cells
treated with ginger oil at both concentration of 0.05% or 0.1%.
4.7.2.1 PDGFR-β
Platelet derived growth factors (PDGF) are secreted by endothelial cells for the formation
of blood vessels in mammals (Hoch and Soriano 2003). These growth factors further activate
receptor tyrosine kinase, PDGFR-β (Hellstrom and others 1999). PDGFR signaling pathway has
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important functions in process of embryogenesis but its over-expression has been found in many
pathological diseases like cancer (Carvalho and others 2005).
4.7.2.2 p-IGF-1R
Insulin-like growth factor 1 receptor is found in phosphorylated condition in all breast
cancer and accounts for poor survival. IFF-1R is a receptor tyrosine kinase that is considered as
oncogene responsible for proliferation, survival, transformation, cell to cell interactions, and
differentiation. Expression of this receptor is fundamental for the process of metastasis and cell
survival (Zhang and others 2011).
4.7.2.3 Human Epidermal Growth Factor Receptor 2 (Her-2)
As shown in figure 4.8, ginger oil dose dependently at concentrations of 0.05% and 0.1%
inhibited the expression of Her-2, which is overexpressed in 25-30% of breast cancers. Its level
is highly increased in malignant cell; it gives aggressive property to tumor. Her2 overexpression
increases the aggressive form of the disease therefore there is less chance of survival of patients.
4.7.3 Effect of Ginger Oil on Expression of Pro-Apoptotic, Anti-Apoptotic and Cell
Survival Proteins
As shown in figure 4.9, ginger oil at concentrations of 0.05% and 0.1% of volume of
media used, could increase the level of pro-apoptotic protein like Bax and at the same time
ginger oil could drop the expression of anti-apoptotic protein like Bcl-2. Literature suggest that
constituents of ginger, galanals A and B can successfully inhibit Bcl-2 and enhance Bax in case
of leukemia (Miyoshi and others 2003).
P38/MAPK pathway regulates variety of cellular responses to stress and inflammation.
Although p38 is considered as inducer of apoptosis and inhibitor of cell proliferation, very high
expression of phosphorylated p38 is found to be associated with cell survival (Esteva and others
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2004; An and others 2011). The level of phosphorylated p38 is considered to be very high in
breast cancer (Mao and others 2010).

Figure 4.8: Expression of Growth Factor Receptors
As shown in figure 4.9, we have found out that ginger oil down regulates the expression
of phosphorylated p38. Our outcomes are consistent with the observations made by others, where
p38 MAPK activity modulated the regulation of several cytokines that included IL-8 and TNF-α.
Researchers have shown that inhibition of p38 activation leads to strong inhibition of Tumor
Necrosis Factor (TNF-α) and Interleukin-8 (IL-8) (Westra and others 2004), which strongly corelates with our findings presented in figure 4.5 and figure 4.13 respectively. Our results suggest
that ginger oil can significantly inhibit the expression of this oncogene, phosphor-p38 at
concentrations as low as 0.05% and 0.1% of volume of the media.
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Figure 4.9: Expression of Proteins Involved in Apoptosis and Survival
4.7.4 Effect of Ginger Oil on Expression of Cell Surface Biomarkers
Our results as shown in figure 4.10, demonstrate that ginger oil was effective against
inhibiting breast cancer stem cell surface biomarkers like Aldh1/CD44/ESA. These data
emphasizes the anti-carcinogenic activity of ginger oil against breast cancer stem cells. Aldh1 is
a marker for normal and malignant human mammary stem cells. Curcumin and piperine have
been reported to inhibit the expression of Aldh1, breast stem cell marker (Kakarala and others
2010). Dietary agents like sulforophane in combination with drug has also been reported to
inhibit Aldh1 (Kallifatidis and others 2011). CD44+ stem cells are found to be resistant against
chemo- or radiation- therapy induced cell death (Takaishi and others 2009). Epithelial –specific
antigen (ESA) is also expressed in breast cancer stem cells and all these biomarkers containing
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breast cancer cells have very good self-renewal potential and are very aggressive with poor
prognosis (Manson and others 2007).

Figure 4.10: Expression of Cell Surface Markers
4.8 Effect of Ginger Oil in Process of Angiogenesis
4.8.1 Effect of Ginger Oil on Endothelial Cell Tube Formation
To determine the effect of ginger oil in the process of angiogenic tube formation, in vitro
angiogenesis kit from Millipore was used. The process of angiogenesis is a multi-step process
and this assay gives the basis for studying the tube formation. The matrix provided in the assay
resembles the basement membrane, and it contains the basement proteins that are required to
form tube. Endothelial cells when place in the matrix, aligns in a way to form a hollow tube. To
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test the inhibitory effect of ginger oil on tube formation, media of the cells untreated and treated
with ginger oil was introduced to the seeded human coronary artery endothelial cells and the
effect was observed after 6 hours.
The results of this experiment showed that in presence of ginger oil at concentrations as
low as 0.05% and 0.1%, endothelial cells alignment was disrupted, which is presented in figure
4.11. While the controls; one with only endothelial cells and the other with endothelial cell with
the media from the untreated MDA-MB-231 cells were able to form highly organized,
extensively aligned capillary-like structure. Researchers have been able to show that [6]gingerol, a pungent compound from ginger is able to inhibit VEGF induced endothelial cell
proliferation and reduced the size of the tube in vitro and in vivo at a concentration of 10 µM
(Kim et al. 2005).
4.8.2 Effect of Ginger Oil on Expression of Angiogenic Biomarkers
4.8.2.1 Vascular Endothelial Growth Factor
To support these results of in vitro angiogenesis, we also analyzed the expression of
vascular endothelial growth factor (VEGF) by western blot. Our results (Figure 4.12) showed
that VEGF expression was significantly reduced in the cells treated with ginger oil at
concentrations of 0.05% and 0.1%. VEGF is a dimeric glycoprotein, which is the most important
growth factor for inducing angiogenesis. High level of VEGF is associated with high malignancy
and poor prognosis in cases of breast cancer (Shibata et al. 2002; Heffelfinger and others 1999).
Angiogenesis is regulated by many molecules and VEGF being one of the very important one. It
is a glycoprotein with a molecular weight of less than 45 kDa. VEGF is expressed highly in
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Figure 4.11: Inhibitory Effect of Ginger Oil on in-vitro Angiogenesis Tube Formation. A: Tubes
Formed by Human Coronary Artery Endothelial Cells (HCAECs). B: Aligned
HCAECs for Tube Formation in Presence of Media from Untreated Cells. C:
Disrupted HCAECs in Presence of the Media from 0.05% GO. D: Disrupted
HCAECs in Presence of the Media from 0.05% GO.
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physiological cases like wound healing and embryonic development and in pathological cases
like cancer. In case of cancer, when a tumor cannot grow beyond a certain size, it starts secreting
VEGF molecules. VEGF receptors are present in endothelial cells, once VEGF molecule binds
itself with these receptors, the physiological response of endothelial cell changes, directing the
growth of blood vessels towards the tumor, eventually supplying nutrients and oxygen.
4.8.2.2 Phospho-erk
Phospho-erk is one of the major biomarker of signalling events for monitoring
angiogenesis (Sessa and others 2008) and is the down streaming molecule in MAPK pathway .
The intracellular signaling cascade involving MAPK /ERK leads to anti-apoptotic pathway and
stimulates growth signals (Stuart and others 2006). As shown in figure 4.12, the results of the
treatment of MDA-MB-231 cells with ginger oil showed inhibition of phosphorylated ERK when
compared with the control.

4.8.2.3 Cathepsin D
Our results show that MDA-MB-231 cells treated with ginger oil had reduced level of
cathepsin D expression. The result is shown in figure 4.12. Cathepsin D is an acidic lysosomal
aspartyl endoprotease and is considered one of the biomarkers of breast cancer. It is reported to
be overexpressed in pathological condition and is responsible for malignancy. Evidences suggest
that the expression of cathepsin D is increased by 2 to 50 times in breast cancer cells as
compared to normal mammary cells or other cells (Capony and others 1989). It plays role in cell
proliferation, apoptosis, extra cellular matrix degradation, activation of growth factors, and
angiogenesis (Leto and others 2004). Literatures suggest that cathepsin D in breast cancer cells,
boosts anchorage-independent cell proliferation leading to tumorigenesis and metastasis (Glondu
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and others 2002). Cathepsin is supposed to be up regualted and heavily secreted in ER negative
MDA-MB-231 cells (Garcia and others 1996). Literatures suggest that MDA-MB-231 cells are
model of breast cancer cells with high cathepsin D level with more metastatic properties, which
makes cathepsin D a potential target for breast cancer therapy (Rochefort and others 2000).
4.8.2.4 Histone Deacetylases (HDACs)
As shown in figure 4.12, HDACs are down regulated with the treatment of ginger oil.
HDACs are the enzymes involved in epigenetics, most commonly in DNA methylation and
acetylation. It controls most of the genes responsible for angiogenesis, cell cycle, and apoptosis
(Shankar and Srivastava 2008). Also histone deacetylase have been reported to induce apoptosis
by up regulating the pro-apoptotic proteins and inhibiting the anti- apoptotic proteins. Histone
inhibitors have also been reported to reduce the level of VEGF expression in tumor cells of mice
(Shankar and others 2005).

Figure 4.12: Expression of angiogenic biomarkers
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4.8.3 Effect of Ginger Oil on Interleukin-8 (IL-8) Levels
To determine the level of expression of IL-8, ELISA was performed. IL-8 is produced
mostly by monocytes, macrophages, T cells and vascular endothelial cells. Its secretion is
regulated by NFκB. IL-8 is reported to function in formation of new micro vessels, tumor
neovascularization, help in tumor growth and metastasis, and activate the ERK2/1 pathway
(Heidemann and others 2003). It has also been found out that the level of IL-8 expression
increases with decrease in the level of estrogen receptor. IL-8 is one of the major molecules
found to be responsible for the properties like invasion and angiogenesis in breast cancer (Lin
and others 2004). Dietary agents such as curcumin, querectin, resveratrol, genistein, green tea
polyphenols, theaflavin, and capsaicin has been reported to down regulate the expression of IL-8
(Hidaka and others 2002; Shen and others 2003; Porath and others 2005). Literatures show that
ginger is able to inhibit the expression of IL-8 in ovarian cancer cells (Rhode and others 2007).
Another group of researchers have shown that ginger extract at a concentration of 100µg/ml was
able to inhibit the expression of chemokines in human synoviocytes (Phan and others 2005).
Researches have shown that ginger can effectively modulate the biochemical pathway in chronic
inflammation with changing expression of various chemokines and cytokines genes including
cyclooxygenase-2 (Grzanna et al. 2005) .
In our study we have used MDA-MB-231 cell line, which is ER- and according to the
findings of Lin et al. as mentioned above the level of IL-8 expression is high in ER- cells. And
this level of IL-8 was significantly dose dependently decreased in the cells treated with 0.05%
and 0.1% of ginger oil. Obtained results are presented in figure 4.13.
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Figure 4.13: Dose Dependent Inhibition of Ginger Oil on the Expression of Interleukin-8 (IL-8).
Values (means ± SD, n=3) not sharing a common letters, ABC are significantly
different (α=0.05).
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CHAPTER 5: SUMMARY AND CONCLUSIONS
Data accumulated from this research propose that dietary phytochemicals, like ginger oil
have the potential to manage deregulated signaling pathways or restore checkpoint pathways and
apoptosis in cancer. Biological activities of ginger oil show promising future in treatment of
cancer. However, this requires further investigation to figure out mode of action of ginger oil and
additional research to determine the amount of regular intake.
In summary, the major finding of this study is that ginger oil inhibits the viability of
breast cancer cells through caspase-mediated pathway, as well as down regulates Hsp90 and its
related client proteins. Ginger Oil induced apoptosis with the increase in caspase activity, cell
cycle arrest in the S-phase and increase in the level of sub-G1 phase. Ginger oil also decreased
protein levels of cyclin D1, cyclin dependent kinase (Cdk)-2, Cdk-4 and Bcl-2 level while it
increased the level of apoptotic proteins such as Bax. In addition, ginger oil inhibited in vitro
angiogenesis and biomarkers associated with angiogenesis. Ginger oil also significantly reduced
the expression of various oncoproteins and repressed the activity of telomerase that are expressed
in breast cancer cells. Hence, ginger oil is an essential oil with various anti-cancer properties. So
far we have demonstrated that ginger oil inhibits hallmarks of breast cancer cells, however, it
remains to demonstrate that ginger oil is also as effective against cancer cells in vivo.
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